Clinical trial
Stop Retinal Ganglion Cell Dysfunction Study
NCT02390284
Study timeline
Study start (actual)2015-09-01Date precision: month
Registry last updated2025-08-26
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Glaucomaverified · MONDO: glaucoma
Interventions
LatanoprostDRUG · verified · RxNorm: latanoprost
BimatoprostDRUG · verified · RxNorm: bimatoprost
TravoprostDRUG · verified · RxNorm: travoprost
TimololDRUG · verified · RxNorm: timolol
DorzolamideDRUG · verified · RxNorm: dorzolamide
BrinzolamideDRUG · verified · RxNorm: brinzolamide
AcetazolamideDRUG · verified · RxNorm: acetazolamide
MethazolamideDRUG · verified · RxNorm: methazolamide
Sponsors & collaborators
University of Miamilead sponsor
National Eye Institute (NEI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02390284 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.